Evidence map›Paper›PMID 32935090›Full record

ArticleResearch square2020

Patient-Reported Health Outcomes After Treatment of COVID-19 with Nebulized and/or Intravenous Neutral Electrolyzed Saline Combined with Usual Medical Care Versus Usual Medical care alone: A Randomized, Open-Label, Controlled Trial.

Ivan Delgado-Enciso, Juan Paz-Garcia, Carlos E Barajas-Saucedo, Karen A Mokay-Ramírez, Carmen Meza-Robles, Rodrigo Lopez-Flores, Marina Delgado-Machuca, Efren Murillo-Zamora, Jose A Toscano-Velazquez, Josuel Delgado-Enciso and 24 more

Open access · goldAbstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in Research square, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 17 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

34 authors at 4 institutions in 3 countries.

Ivan Delgado-EncisoUniversidad de Colima Facultad de Medicina.ORCID 0000-0001-9848-862X
Juan Paz-GarciaCentro Hospitalario Unión, Villa de alvarez, colima.
Carlos E Barajas-SaucedoUniversidad de Colima Facultad de Medicina.
Karen A Mokay-RamírezUniversidad de Colima Faculty of Medicine: Universidad de Colima Facultad de Medicina.
Carmen Meza-RoblesDepartament of research Cancerology State Institute of Colima.
Rodrigo Lopez-FloresDepartament of research Cancerology State Institute of Colima.
Marina Delgado-MachucaDepartament of research Cancerology State Institute of Colima.
Efren Murillo-ZamoraDepartament of research General Hospital of Zone No. 1 IMSS, Villa de alvarez, Colima.
Jose A Toscano-VelazquezUniversidad de Colima Faculty of Medicine: Universidad de Colima Facultad de Medicina.
Josuel Delgado-EncisoDepartament of research Foundation for Cancer Ethics, education and Research of the Cancerology State Institute.
Valery MelnikovUniversidad de Colima Facultad de Medicina.
Mireya Walle-GuillenUniversidad de Colima Facultad de Medicina.
Hector R Galvan-SalazarDepartament of research Cancerology State Institute of Colima.
Osiris G Delgado-EncisoDepartament of research foundation for Cancer Ethics, Education and Research of the Cancerology State Institute.
Ariana Cabrera-LiconaDepartament of research, Esteripharma.
José Guzman-EsquivelDepartament of research, General Hospital of zone no. 1 IMSS, Villa de Alvarez, Colima.
Daniel A Montes-GalindoInstitute of Cancerology: Instituto de Cancerologia.
Alejandra E Hemandez-RangelUniversidad de Colima Facultad de Medicina.
Patricia Montes-DiazPrivate medical office Xochitepec.
Iram P Rodriguez-SanchezDepartament of research Hospital of zone no.1 imss Villa de alvarez, Colima.
Margarita L Martinez-FierroMolecular medicine laboratory: Academic unit of human medicine and health sciences.
Idalia Garza-VelozMolecular medicine laboratory, Academic unit of Human medicine and health sciences.
Daniel Tiburcio-JimenezUniversidad de Colima Faculty of Medicine: Universidad de Colima Facultad de Medicina.
Sergio A Zaizar-FregosoUniversidad de Colima Faculty of Medicine: Universidad de Colima Facultad de Medicina.
Mario Ramirez-FloresUniversidad de Colima Faculty of Medicine: Universidad de Colima Facultad de Medicina.
Gustavo Gaytan-SandovalDepartament of research Cancerology State Institute of Colima.
Carlos R Martinez-PerezDepartament of research Cancerology State Institute of Ciolima.
Francisco Espinoza-GómezUniversidad de Colima Facultad de Medicina.
Fabián Rojas-LariosUniversidad de Colima Facultad de Medicina.
Michael J Hirsch-MeillonDepartament of research Cancerology State Institute of Colima.
Enrique Barrios-NavarroUniversidad de Colima Facultad de Medicina.
Vladimir Oviedo-RodriguezDepartament of research Cancerology State Institute of Colima.
Luz M Baltazar RodriguezUniversidad de Colima Faculty of Medicine: Universidad de Colima Facultad de Medicina.
Brenda A Paz-MichelAutonomous University of Nueo León.ORCID 0000-0001-7137-6505
Hospital General De Zona · MXUniversidad de Colima · MXInstituto Nacional de Cancerología · MXSciencePharma (Poland) · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID32935090
PMCPMC7491578
OpenAlexW3086783775

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.